Eikon Therapeutics

Transforms biology into life-saving therapies.

📋 Overview of Eikon Therapeutics

Founding Year

2019

Estimated Funding

$0000

Size

$0000

Locations

Hayward

Primary Industry

Biotechnology, Industry

📙 About Eikon Therapeutics

Eikon Therapeutics is a biopharmaceutical company dedicated to advancing breakthrough medicines by merging engineering with science. Using proprietary technologies like single-molecule tracking (SMT) and super-resolution microscopy, it deciphers the dynamic behaviors of proteins to discover and develop innovative therapies. It addresses critical unmet needs in oncology, immunology, and neuroscience, aiming to transform patient outcomes with precision-targeted treatments and advanced drug discovery platforms.

💰 Recent Investors of Eikon Therapeutics

Abu Dhabi Investment Authority, AME Cloud Ventures, Investor

© 2025 Bot Memo. All Rights Reserved.

Subscribe to Bot Memo

As as subscriber, you can explore more AI startups. You also get exclusive AI market gap reports every fortnight in your inbox.*

Continue with Google *We hate spam as much as you do.